DALLAH HEALTHCARE COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167 SAR | +0.72% |
|
+3.47% | -2.79% |
| Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
Evolution of the average Target Price on Dallah Healthcare Company
Price target over the last 5 years
History of analyst recommendation changes
2361329bf385f53206.8VXzO2pg9LW5tuKuRj86D9bkBxx93MFZFRLEGbQQ2i0.wyW5CQRRkvj6-9bPJ0t0YKaHZCRJhpE6XUWLcv9k6kHDDbF-Lhiuw-bdpw~f8dfd245e3a0b6fc49dbe98ed02fa2b4
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
167
SAR
Average target price
154.4
SAR
Spread / Average Target
-7.56%
High Price Target
183
SAR
Spread / Highest target
+9.58%
Low Price Target
106
SAR
Spread / Lowest Target
-36.53%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4004 Stock
- Consensus Dallah Healthcare Company
